NewsBenzingaTranscripción de la conferencia telefónica sobre resultados del segundo trimestre de 2026 de Amylyx Pharma Transcripción de la conferencia telefónica sobre resultados del segundo trimestre de 2026 de Amylyx Pharma Benzinga 2026.10.05 11:25 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Overweight on Coca-Cola Europacific, Lowers Price Target to $115 GameStop CEO Ryan Cohen Keeps Buying: Two New Filings in One Week Wells Fargo Maintains Overweight on Anheuser-Busch InBev, Lowers Price Target to $88 Highest Yielding Hyperscaler Bonds in October 2026: SpaceX Joins Oracle Above 7.5% NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M Maris-Tech Receives Pilot Order For Armored Vehicle Situational Awareness Application
NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M
